185 related articles for article (PubMed ID: 25307283)
1. The effect of sulforaphane on histone deacetylase activity in keratinocytes: Differences between in vitro and in vivo analyses.
Dickinson SE; Rusche JJ; Bec SL; Horn DJ; Janda J; Rim SH; Smith CL; Bowden GT
Mol Carcinog; 2015 Nov; 54(11):1513-20. PubMed ID: 25307283
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly.
Rajendran P; Delage B; Dashwood WM; Yu TW; Wuth B; Williams DE; Ho E; Dashwood RH
Mol Cancer; 2011 May; 10():68. PubMed ID: 21624135
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
Clarke JD; Hsu A; Yu Z; Dashwood RH; Ho E
Mol Nutr Food Res; 2011 Jul; 55(7):999-1009. PubMed ID: 21374800
[TBL] [Abstract][Full Text] [Related]
4. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.
Myzak MC; Karplus PA; Chung FL; Dashwood RH
Cancer Res; 2004 Aug; 64(16):5767-74. PubMed ID: 15313918
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane suppresses in vitro and in vivo lung tumorigenesis through downregulation of HDAC activity.
Jiang LL; Zhou SJ; Zhang XM; Chen HQ; Liu W
Biomed Pharmacother; 2016 Mar; 78():74-80. PubMed ID: 26898427
[TBL] [Abstract][Full Text] [Related]
6. HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates.
Rajendran P; Kidane AI; Yu TW; Dashwood WM; Bisson WH; Löhr CV; Ho E; Williams DE; Dashwood RH
Epigenetics; 2013 Jun; 8(6):612-23. PubMed ID: 23770684
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.
Choi SY; Kee HJ; Jin L; Ryu Y; Sun S; Kim GR; Jeong MH
Biomed Pharmacother; 2018 May; 101():145-154. PubMed ID: 29482060
[TBL] [Abstract][Full Text] [Related]
8. Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition.
Tortorella SM; Royce SG; Licciardi PV; Karagiannis TC
Antioxid Redox Signal; 2015 Jun; 22(16):1382-424. PubMed ID: 25364882
[TBL] [Abstract][Full Text] [Related]
9. Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds.
Nian H; Delage B; Ho E; Dashwood RH
Environ Mol Mutagen; 2009 Apr; 50(3):213-21. PubMed ID: 19197985
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6.
Gibbs A; Schwartzman J; Deng V; Alumkal J
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16663-8. PubMed ID: 19805354
[TBL] [Abstract][Full Text] [Related]
11. Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition.
Rajendran P; Johnson G; Li L; Chen YS; Dashwood M; Nguyen N; Ulusan A; Ertem F; Zhang M; Li J; Sun D; Huang Y; Wang S; Leung HC; Lieberman D; Beaver L; Ho E; Bedford M; Chang K; Vilar E; Dashwood R
Cancer Res; 2019 Mar; 79(5):918-927. PubMed ID: 30643017
[TBL] [Abstract][Full Text] [Related]
12. The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.
Abbaoui B; Telu KH; Lucas CR; Thomas-Ahner JM; Schwartz SJ; Clinton SK; Freitas MA; Mortazavi A
J Proteomics; 2017 Mar; 156():94-103. PubMed ID: 28132875
[TBL] [Abstract][Full Text] [Related]
13. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention.
Ho E; Clarke JD; Dashwood RH
J Nutr; 2009 Dec; 139(12):2393-6. PubMed ID: 19812222
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.
Myzak MC; Hardin K; Wang R; Dashwood RH; Ho E
Carcinogenesis; 2006 Apr; 27(4):811-9. PubMed ID: 16280330
[TBL] [Abstract][Full Text] [Related]
15. Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs.
Okonkwo A; Mitra J; Johnson GS; Li L; Dashwood WM; Hegde ML; Yue C; Dashwood RH; Rajendran P
Mol Nutr Food Res; 2018 Sep; 62(18):e1800228. PubMed ID: 29924908
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells.
Yang F; Wang F; Liu Y; Wang S; Li X; Huang Y; Xia Y; Cao C
Life Sci; 2018 Nov; 213():149-157. PubMed ID: 30352240
[TBL] [Abstract][Full Text] [Related]
17. Sodium propionate and sodium butyrate effects on histone deacetylase (HDAC) activity, histone acetylation, and inflammatory gene expression in bovine mammary epithelial cells.
Silva LG; Ferguson BS; Avila AS; Faciola AP
J Anim Sci; 2018 Dec; 96(12):5244-5252. PubMed ID: 30252114
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice.
Myzak MC; Dashwood WM; Orner GA; Ho E; Dashwood RH
FASEB J; 2006 Mar; 20(3):506-8. PubMed ID: 16407454
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of non-hydroxamate histone deacetylase inhibitors: identification of a selective histone acetylating agent.
Suzuki T; Matsuura A; Kouketsu A; Hisakawa S; Nakagawa H; Miyata N
Bioorg Med Chem; 2005 Jul; 13(13):4332-42. PubMed ID: 15927839
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane.
Myzak MC; Dashwood RH
Curr Drug Targets; 2006 Apr; 7(4):443-52. PubMed ID: 16611031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
